Psychedelic Research Chemicals or RC Chems are new synthetic substances which are structurally similar to the original drug, while being functional analogs. Data on their effects limited due as they’re fairly new and do not have a lot of human consumption history.

Psychedelics are substances (natural or laboratory made) which cause profound changes in a one’s perceptions of reality. While under the influence of hallucinogens, users might hallcuniate visually and auditorily.

Disclaimer: Psychedelic drugs offer some of the most powerful and intense psychological experiences. Additionally these substances are illegal in many places. We understand that even though these substances are illegal, their use occurs frequently. We do not condone breaking of the law. By providing accurate information about these substances, we encourage the user to make responsible decisions and practice harm reduction.

Read the full disclaimer here.

Practice Harm Reduction. Proceed with Caution.


5-MeO-DALT Also known as:

  • 1H-Indole-3-ethanamine, 5-methoxy-N,N-di-2-propen-1-yl-[ACD/Index Name]
  • 5-MeO-DALT
  • 5-MeO-DALT solution
  • MFCD11655942[MDL number]
  • n,n-diallyl-5-methoxytryptamine
  • N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-propen-1-amin[German][ACD/IUPAC Name]
  • N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2-propen-1-amine[ACD/IUPAC Name]
  • N-Allyl-N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]-2-propén-1-amine[French][ACD/IUPAC Name]
  • N-Allyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-en-1-amine
  • V25VK0QTAA
  • [928822-98-4]
  • 10.1016/j.bmcl.2013.03.066
  • 5-MeO-DALT (5-Methoxy-N,N-diallyltryptamine)
  • 5-MeO-DALT (5-Methoxy-N,N-diallyltryptamine) 1.0 mg/ml in Acetonitrile
  • 5-methoxy DALT
  • 5-methoxy-N,N-di-2-propen-1-yl-1H-indole-3-ethanamine
  • 5-Methoxy-N,N-diallyl-1H-indole-3-ethanamine
  • 5-Methoxy-N,N-diallyltryptamine
  • '928822-98-4
  • BR-27697
  • N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enyl-2-propen-1-amine
  • N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine
  • N-2-(5-methoxy-1H-indole-3-yl)ethyl-N-(prop-2-en-1-yl)prop-2-en-1-amine[ACD/IUPAC Name]
  • N-Allyl-N-(2-(5-methoxy-1H-indol-3-yl)ethyl)prop-2-en-1-amine
  • QA-3151

A strange drug with an unknown mechanism of action. Some psychedelic effects alongside some effects non-characteristic of psychedelics like appetite enhancement. Reported as having rapid, intense and short acting entheogenic effects.


It is structurally related to tryptamines like 5-MeO-DiPT and DALT, although it is reported to produce distinct effects. 5-MeO-DALT was first synthesized by Alexander Shulgin, who sent the first material regarding the synthesis and effects to a researcher in May 2004. This material was subsequently circulated online and the compound soon appeared on the online research chemical market.

In August 2004, the synthesis and effects of 5-MeO-DALT were officially published by Erowid. Reports linked to the detection of 5-MeO-DALT began to surface in 2007. Anecdotal reports characterize the effects of this substance as being primarily physical in nature, lacking the characteristic visual distortions or perceptual depth of most psychedelics.

Its headspace has been described as “shallow,” albeit suited for sexual contexts due to its potent stimulating and libidinous effects. It is also reported to produce more uncomfortable cardiovascular effects such as increased blood pressure and heart rate relative to other psychedelics. This has raised questions about possible toxicity associated with long-term or heavy uses.

Very limited data exists about the pharmacological properties, metabolism, and toxicity of 5-MeO-DALT, and it has a very short history of human use. It is highly advised to use harm reduction practices if using this substance.




It contains two allyl groups bound to the amino group and a 5-methoxy group bound to the indole ring of tryptamine.

It is a structural analog of DALT and 5-MeO-DiPT.

5-MeO-DALT is an off-white powder at room temperature.

Common Name5-MeO-DALT
Systematic name5-MeO-DALT
Std. InChiInChI=1S/C17H22N2O/c1-4-9-19(10-5-2)11-8-14-13-18-17-7-6-15(20-3)12-16(14)17/h4-7,12-13,18H,1-2,8-11H2,3H3
Avg. Mass270.3694 Da
Molecular Weight270.3694
Monoisotopic Mass270.173218 Da
Nominal Mass270
ChemSpider ID21106245

Subscribe for the latest updates

Dose Chart


Duration Chart

Duration2-4 hours
After-effects1-2 hours

Auditory Effects

Psychological Effects

The headspace of 5-MeO-DALT is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high doses.

Pharmacological Effects

5-MeO-DALT acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from its efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience remains the subject of ongoing scientific investigation.

Physical Effects

Sensory Effects

  • Synaesthesia - In its fullest manifestation, this is a very rare and non-reproducible effect. Increasing the dosage can increase the likelihood of this occurring, but seems to only be a prominent part of the experience among those who are already predisposed to synaesthetic states.

Subjective Effects

Disclaimer: The effects listed below are cited from the Subjective Effect Index (SEI), which relies on assorted anecdotal reports and the personal experiences of PsychonautWiki contributors. As a result, they should be taken with a healthy amount of skepticism. It is worth noting that these effects will not necessarily occur in a consistent or reliable manner, although higher doses (common+) are more likely to induce the full spectrum of reported effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death.

Visual Effects




The visual geometry that is present throughout the experience can be described as more similar in appearance to that of AMT than that of LSD, 2C-B or 2C-I. It can be comprehensively described as unstructured in its organization, synthetic in geometric style, intricate in complexity, small in size, slow and smooth in motion, colourful in scheme, glossy in colour, equally blurred and sharp in its edges and equally rounded and angular in its corners. It possesses a synthetic feel that is less impressive than most of the "classical" psychedelics at any level. It has yet to be confirmed whether this compound results in either level 8A or level 8B geometry at heavy doses.

Legal Status

  • Austria: Since January 1, 2012, 5-MeO-DALT is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).
  • China: 5-MeO-DALT is a controlled substance in China as of October 2015.
  • Germany: 5-MeO-DALT is controlled under the NpSG (New Psychoactive Substances Act) as of July 18, 2019. Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.
  • Japan: 5-MeO-DALT became a controlled substance in Japan in April 2007 due to an amendment to the Pharmaceutical Affairs Law.
  • Sweden: 5-MeO-DALT is a Schedule I substance in Sweden as of May 1, 2012. It was published by Medical Products Agency in their regulation LVFS 2012:6.
  • United Kingdom: 5-MeO-DALT is a Class A drug in the UK as it is an ether of the drug 5-HO-DALT, which is a Class A drug as a result of the tryptamine catch-all clause.
  • United States: 5-MeO-DALT is unscheduled in the United States. It may be considered an analogue of 5-MeO-DiPT, a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.
    • Florida: 5-MeO-DALT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.
  • Sources


    2. Brandt, S. D., Kavanagh, P. V., Dowling, G., Talbot, B., Westphal, F., Meyer, M. R., ... & Halberstadt, A. L. (2017). Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives. Drug Testing and Analysis, 9(1), 115-126.
    3. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
    4. "Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes" (PDF) (in German). Bundesanzeiger Verlag. Retrieved December 10, 2019.
    5. "Anlage NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 10, 2019.
    6. "§ 4 NpSG" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 10, 2019.
    7. "厚生労働省:平成18年度無承認無許可医薬品等買上調査の結果について". Retrieved 2012-06-26.
    9. Misuse of Drugs Act 1971 ( |
    10. Misuse of Drugs Act 1971 ( |
    11. Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL

    Information made possible with:

    1. PsychonautWiki is a community-driven online encyclopedia that aims to document the field of psychonautics in a comprehensive, scientifically-grounded manner.
    2. Erowid is a non-profit educational & harm-reduction resource with 60 thousand pages of online information about psychoactive drugs
    3. PubChem National Center for Bio Informatics
    4. Chemspider is a free chemical structure database providing fast access to over 34 million structures, properties and associated information.
    5. Wikipedia

    Additional APIs were used to construct this information. Thanks to ChemSpider, NCBI, PubChem etc.

    Data is constantly updated so please check back later to see if there is any more available information on this substance.